effect of mahaneela varti anjana in avarna shukla ayurvedic drug trial on avarna shukla.

A Single-arm clinical study of mahaneela varti anjana in avarna shukla

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/08/015540

Enrollment

Registered

2018-08-30

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Avarna shukla,corneal opacity

Interventions

Intervention1: Mahaneela varti Anjana: Combination of fine powdered drugs including brihati,yashtimadhu,shunti,aamlaki,tamra,shaindhav triturating in Aamalaki rasa dose-application anjana apllied by s

Eligibility

Inclusion criteria

Inclusion criteria: patients suffering form signs and symptoms Avarna shukra(corneal opacity grade 1 and 2)

Exclusion criteria

Exclusion criteria: Svrana shukla,anjana anarha,corneal opacties with complications like adherent leucoma,corneal facet,kerectasia anterior staphyloma

Design outcomes

Primary

Measure	Time frame
Effect of mahaneela varti anjana in Avrana shuklaTimepoint: The drug will be given for 21 days.the patients will be assessed before and after treatment.total duration of study will be 18 months.	—

Secondary

Measure	Time frame
To get relief from symptoms of Avarna shuklaTimepoint: 18 months	—

Countries

India

Contacts

Public ContactVd Shubhangi Bhausaheb Mhaske

Sumatibhai Shah Ayurved Mahavidyala

drnspradhan@yahoo.com9423580963

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026